News

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...
As Congress finalizes a sweeping new federal spending bill, healthcare providers are sounding the alarm over what could be at ...
The Food and Drug Administration approved the preventative use of lenacapavir, made by Gilead Sciences, on Wednesday. Experts ...
The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across ...
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
While Gilead Sciences' HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made- ...
The United States has given its approval to the world’s first twice-a-year injection for HIV prevention, marking a ...
A revolutionary new preventative medicine that protects against the HIV virus has just been approved by the U.S. Food and ...